Judgment of the Court (Sixth Chamber), 10 April 2014

Acino AG v European Commission

Appeal — Medicinal products for human use — Suspension of the marketing and the withdrawal of certain consignments of medicinal products containing the active ingredient Clopidogrel — Variation of marketing authorisations — Prohibition on marketing — Regulation (EC) No 726/2004 and Directive 2001/83/EC — Precautionary principle — Proportionality — Obligation to state reasons

Case C‑269/13 P



Top of the page Documents in the Case
Document Date Name of the parties Subject-matter Curia EUR-Lex Autres Liens
Judgment (OJ)
16/05/2014 Acino v Commission
Judgment
ECLI:EU:C:2014:255
10/04/2014 Acino v Commission
Judgment (Summary)
ECLI:EU:C:2014:255
10/04/2014 Acino v Commission
Application (OJ)
12/07/2013 Acino v Commission
Top of the page Legal analysis of the decision or of the case

Reports of Cases

published in the electronic Reports of Cases (Court Reports - general)

Subject-matter

Information not available

Systematic classification scheme

1.
3 Legal proceedings
  3.10 Appeals
    3.10.02 Jurisdiction over the appeal
      3.10.02.01 Exclusion of questions of fact
        3.10.02.01.01 Incorrect assessment of the facts and evidence
          3.10.02.01.01.00 General
3 Legal proceedings
  3.10 Appeals
    3.10.03 Grounds of appeal
      3.10.03.02 Issues relating to the admissibility of the pleas
        3.10.03.02.03 Repetition of pleas in law and arguments put forward at first instance
4 Internal policy of the European Union
  4.11 Approximation of laws
    4.11.02 Public procurement
      4.11.02.02 General rules applicable to public contracts
4 Internal policy of the European Union
  4.11 Approximation of laws
    4.11.14 Pharmaceutical and cosmetic products
      4.11.14.01 Medicinal products for human use
        4.11.14.01.04 Marketing authorisation
          4.11.14.01.04.03 Amendment of authorisation
4 Internal policy of the European Union
  4.11 Approximation of laws
    4.11.14 Pharmaceutical and cosmetic products
      4.11.14.01 Medicinal products for human use
        4.11.14.01.04 Marketing authorisation
          4.11.14.01.04.00 General
2 Institutional framework of the European Union
  2.05 Legal acts of the European Union
    2.05.06 Statement of reasons
4 Internal policy of the European Union
  4.11 Approximation of laws
    4.11.14 Pharmaceutical and cosmetic products
      4.11.14.01 Medicinal products for human use
        4.11.14.01.04 Marketing authorisation
          4.11.14.01.04.00 General


Citations of case-law or legislation

References in grounds of judgment

Operative part

Opinion

Information not available


Dates

Date of the lodging of the application initiating proceedings

  • 15/05/2013

Date of the Opinion

Information not available

Date of the hearing

Information not available

Date of delivery

10/04/2014


References

Publication in the Official Journal

Judgment: OJ C 175 from 10.06.2014, p.14

Application: OJ C 215 from 27.07.2013, p.8

Name of the parties

Acino v Commission

Notes on Academic Writings

  1. Roset, Sébastien: Autorisation de mise sur le marché des médicaments, Europe 2014 Juin nº 6 p.23 (FR)



Procedural Analysis Information

Source of the question referred for a preliminary ruling

Information not available

Subject-matter

  • Public health

Provisions of national law referred to

Information not available

Provisions of international law referred to

Information not available

Procedure and result

  • Actions for annulment
  • Appeals : dismissal on substantive grounds
  • Appeals : dismissal on grounds of inadmissibility

Formation of the Court

sixième chambre (Cour)

Judge-Rapporteur

Biltgen

Advocate General

Bot

Language(s) of the Case

  • German

Language(s) of the Opinion

    Information not available